Status:

COMPLETED

Detection of GABHS in Throat Gargle

Lead Sponsor:

Gargle Tech

Conditions:

Group A Streptococcus: B Hemolytic Pharyngitis

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this study is to investigate the use of patient throat gargle as an alternative to throat swabbing for the diagnosis of pharyngitis caused by Group A β-Hemolytic Streptococcus (GABHS)...

Detailed Description

The aim of this study is to procure a detailed quantitative and qualitative analysis of GABHS present in patient throat gargle and to compare various culturing techniques and immunoassay methods for e...

Eligibility Criteria

Inclusion

  • Age 18 years or older.
  • Suspected of suffering from GABHS pharyngitis.
  • Able to communicate with study personnel (English or Hebrew).
  • Able to understand oral and written information about the study.
  • Willing to provide written informed consent to participate in the study.

Exclusion

  • Not capable of gargling 10-15 mL fluid.
  • Diagnosed or self-reported pregnancy.
  • History of dementia, cognitive impairment, or psychiatric or mental disorders.

Key Trial Info

Start Date :

February 12 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 16 2019

Estimated Enrollment :

34 Patients enrolled

Trial Details

Trial ID

NCT03231098

Start Date

February 12 2018

End Date

February 16 2019

Last Update

December 10 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

TEREM Ha'Gdud Ha'Ivri Family Clinic

Jerusalem, Israel, 9234502